JPET Celsis microsomes equal better data

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by WEDD, A. M.
Right arrow Articles by GOSSELIN, R. E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by WEDD, A. M.
Right arrow Articles by GOSSELIN, R. E.
Journal of Pharmacology And Experimental Therapeutics, Vol. 75, Issue 3, 251-259, 1942
Copyright © 1942 by American Society for Pharmacology and Experimental Therapeutics


THE ACTION OF QUINIDINE ON THE COLD BLOODED HEART

A. M. WEDD 1, H. A. BLAIR 1, and R. E. GOSSELIN 1

1 From the Departments of Medicine and Physiology, University of Rochester School of Medicine and Dentistry, Rochester, New York

Studies made on driven strips of turtle auricle and ventricle have shown that quinidine does not alter significantly the absolute refractory period. The refractory period and the Q-T interval have again been found to be practically equal, and this holds both normally and under quinidine action. The threshold for electrical stimuli is raised promptly and in consequence conduction in muscle is slowed, in about the same proportion. The drug slows the rate of beating of the heart of the pithed turtle and of the isolated frog heart. The P-R interval of the rhythmically driven turtle heart, in situ or isolated, is not appreciably lengthened at a time when conduction in auricle and ventricle is markedly slowed. Variation of Q-T interval with rate of beating is the same after the drug as before. It is concluded that the principal effects of the drug can be ascribed to rise of threshold and its consequences. Therapeutic use of the drug is indicated primarily in the re-entrant tachycardias, for in them slowing of conduction within the muscle may permit the normal pacemaker to re-establish control.

Submitted on March 16, 1942







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1942 by the American Society for Pharmacology and Experimental Therapeutics.